Banco Bilbao Vizcaya Argentaria S.A. Boosts Eli Lilly and Company Holdings

The Spanish bank increased its stake in the pharmaceutical giant by 74.4% in the third quarter.

Mar. 15, 2026 at 8:21am

Got story updates? Submit your updates here. ›

Banco Bilbao Vizcaya Argentaria S.A., a major Spanish bank, boosted its holdings in Eli Lilly and Company (NYSE:LLY) by 74.4% during the third quarter of 2026, according to a recent SEC filing. The bank now owns 72,043 shares of the pharmaceutical company's stock, valued at $54,656,000.

Why it matters

Eli Lilly is one of the world's largest pharmaceutical companies, known for its innovative medicines and therapies. This significant increase in holdings by a major European bank signals continued investor confidence in Lilly's long-term growth prospects.

The details

According to the SEC filing, Banco Bilbao Vizcaya Argentaria S.A. acquired an additional 30,730 shares of Eli Lilly and Company during the third quarter, bringing its total holdings to 72,043 shares. This represents a 74.4% increase in the bank's position in the pharmaceutical giant.

  • Banco Bilbao Vizcaya Argentaria S.A. filed the SEC report detailing the increased Eli Lilly holdings in the third quarter of 2026.

The players

Banco Bilbao Vizcaya Argentaria S.A.

A major Spanish bank with a significant global presence and investments in various sectors, including pharmaceuticals.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana, known for its innovative medicines and therapies.

Got photos? Submit your photos here. ›

The takeaway

Banco Bilbao Vizcaya Argentaria S.A.'s substantial increase in its Eli Lilly and Company holdings reflects the bank's confidence in the pharmaceutical company's long-term growth potential. This move highlights the continued investor interest in Eli Lilly's innovative products and pipeline.